Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

3237004 Title: PRÉVISION DU RÉSULTAT DE TRAITEMENT AVEC UN ANTICORPS DIRIGÉ CONTRE L'INTÉGRINE ANTI-ALPHA4 BETA7

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
158738344
WO application number:
US2015000476
Type:
European patent granted for BE
Status:
Open
Publication number:
3237004
WO publication number:
WO2016105572
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
23/12/2015
Grant date:
08/05/2024
EP publication date:
01/11/2017
WO publication date:
30/06/2016
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
08/05/2024
EP B1 publication date:
08/05/2024
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
23/12/2035

Applicant

Name:
Takeda Pharmaceutical Company Limited
Legal Form:
From:
08/05/2024
Address:
1-1, Doshomachi 4-chome, Chuo-ku,, Osaka-shi, Osaka, Japan (JP)
To:

Inventor

1

Name:
ROSARIO, Maria
Legal Form:
Address:
Mystic, CT 06355, United States (US)

2

Name:
WYANT, Timothy, L.
Legal Form:
Address:
Bellingham, MA 02019, United States (US)

3

Name:
ABHYANKAR, Brihad
Legal Form:
Address:
Watford WD17 3BY, United Kingdom (GB)

Priority

1

Priority patent number:
201562132917 P
Priority date:
13/03/2015
Priority country:
United States (US)

2

Priority patent number:
201562117750 P
Priority date:
18/02/2015
Priority country:
United States (US)

3

Priority patent number:
201462096636 P
Priority date:
24/12/2014
Priority country:
United States (US)

Classification

IPC or IDT classification:
A61K 39/395; C07K 16/28; G01N 33/68; A61K 39/00;

Publication

Bulletin

Bulletin heading:
EP2
Journal edition number:
2024/09
Publication date:
27/05/2024
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

European Patent Bulletin

Issue number:
202419
Publication date:
08/05/2024
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
30/06/2025
Annual fee number:
10
Annual fee amount:
185 Euro
Penalty fee amount:
85 Euro
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type